X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.globenewswire.com/news-release/2024/01/31/2821045/30757/en/Dare%CC%81-Bioscience-Announces-Positive-End-of-Phase-2-Meeting-with-FDA-on-Development-of-Sildenafil-Cream-3-6-in-Female-Sexual-Arousal-Disorder-and-Provides-Company-Focus-Areas-for-20.html
https://www.globenewswire.com/news-release/2023/12/05/2790860/0/en/Aspargo-Laboratories-Inc-Announces-Completion-of-Dosing-of-All-Subjects-in-Sildenafil-Oral-Suspension-Bioavailability-Study-and-Initiation-of-Dosing-in-Companion-Food-Effect-Study.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214556
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/meta-herbal-issues-voluntary-nationwide-recall-magnum-xxl-9800-capsules-due-presence-undeclared
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/noahs-wholesale-llc-issues-voluntary-nationwide-recall-rock-due-presence-undeclared-sildenafil
https://www.globenewswire.com//news-release/2023/11/01/2771075/30757/en/Dar%C3%A9-Bioscience-Announces-Additional-Positive-Data-from-Phase-2b-RESPOND-Study-of-Sildenafil-Cream-3-6-in-Women-and-Proposed-Endpoints-and-Patient-Population-for-Phase-3-Program.html
https://www.globenewswire.com//news-release/2023/09/19/2745556/0/en/Aspargo-Laboratories-Inc-Announces-Initial-Dosing-of-All-Subjects-in-Bioavailability-Study-for-Sildenafil-Oral-Suspension.html
https://www.globenewswire.com//news-release/2023/09/05/2737281/0/en/Aspargo-Laboratories-Announces-IND-Clearance-by-U-S-FDA-Enabling-Launch-of-Bioequivalence-and-Food-Effect-Studies-for-Sildenafil-Oral-Spray.html
https://www.globenewswire.com//news-release/2023/08/16/2726284/0/en/Mangoceuticals-Launches-New-Sildenafil-Based-Erectile-Dysfunction-Product-with-Signature-Mango-Flavor-Rapid-Dissolve.html
https://www.globenewswire.com/news-release/2023/08/01/2715760/0/en/Aspargo-Laboratories-Inc-Announces-Filing-of-Its-Investigational-New-Drug-Application-for-Sildenafil-Oral-Spray.html
https://www.globenewswire.com/news-release/2023/07/11/2702582/30757/en/Dar%C3%A9-Bioscience-Announces-Additional-Positive-Data-from-Exploratory-Phase-2b-RESPOND-Study-of-Sildenafil-Cream-3-6-in-Women.html
https://www.globenewswire.com/news-release/2023/06/21/2691955/0/en/Mangoceuticals-Inc-Announces-Upcoming-Launch-of-its-Sildenafil-Based-Mango-Flavored-Rapid-Dissolve-ED-Product.html
https://www.globenewswire.com/news-release/2023/06/05/2681882/30757/en/Dar%C3%A9-Bioscience-Announces-Positive-Topline-Data-from-the-Exploratory-Phase-2b-RESPOND-Study-of-Sildenafil-Cream-3-6-in-Women-with-Female-Sexual-Arousal-Disorder.html
https://www.pharmacompass.com/pdf/news/volt-candy-issues-voluntary-nationwide-recall-of-primezen-black-6000-capsules-due-to-presence-of-sildenafil-and-tadalafil-4249.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214773
https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-rosemont-pharmaceuticals-ltd-atorvastatin-4mg-slash-ml-oral-suspension-and-sildenafil-10mg-slash-ml-oral-suspension-el-22-a-slash-39
https://www.globenewswire.com/news-release/2022/08/29/2505893/30757/en/Dar%C3%A9-Bioscience-Announces-Interim-Analysis-of-Phase-2b-RESPOND-Study-of-Sildenafil-Cream-3-6-in-Women-with-Female-Sexual-Arousal-Disorder.html
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-produits-de-bien-tre-bodis-red-woody-go-rilla-undeclared-prescription-drug-sildenafil-1654327352.pdf
https://www.globenewswire.com/news-release/2022/05/04/2435610/0/en/Aspargo-Acquires-Bandol-Sildenafil-Spray-Currently-Marketed-In-Spain.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211638
https://www.globenewswire.com/news-release/2022/03/03/2396551/0/en/CURE-Pharmaceutical-and-Milagro-Pharmaceuticals-Collaborate-for-Registration-and-Approval-to-Sell-Sildenafil-Oral-Thin-Film-in-Mexico.html
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/celebrate-today-issues-voluntary-nationwide-recall-one-lot-red-mammoth-due-presence-undeclared
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abc-sales-1-inc-issues-voluntary-nationwide-recall-mac-daddy-red-and-mac-daddy-purple-capsules-due
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214641
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215522
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212312
https://www.jdsupra.com/legalnews/ontario-superior-court-dismisses-apotex-3172212/
https://www.hopkinsmedicine.org/news/newsroom/news-releases/a-cousin-of-viagra-reduces-obesity-by-stimulating-cells-to-burn-fat-study-shows#:~:text=These%20findings%2C%20published%20online%20Oct,their%20ovaries%2C%20thus%20mimicking%20menopause.
https://www.pharmacompass.com/pdf/news/yamtun7-issues-voluntary-nationwide-recall-of-poseidon-platinum-3500-1620795419.pdf
https://www.pharmacompass.com/pdf/news/ns-ny-distributor-inc-issues-voluntary-nationwide-recall-of-premium-orgazen-7000-1618506818.pdf
https://www.pharmacompass.com/pdf/news/adamssecretco-issues-voluntary-nationwide-recall-of-adams-secret-extra-strength-1613545998.pdf
https://www.pharmacompass.com/pdf/news/avkare-issues-voluntary-nationwide-recall-of-sildenafil-100mg-tablets-and-trazodone-1607667873.pdf
https://www.pharmacompass.com/pdf/news/the-protein-shoppe-llc-issues-voluntary-nationwide-recall-of-the-red-e-male-enhancement-tablet-1599639080.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209302
https://www.eurekalert.org/pub_releases/2020-08/lu-pdl081720.php#:~:text=A%20new%20study%20from%20Lund,is%20the%20most%20well%2Dknown.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213041
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208494
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213032
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pharmascience-incs-pms-sildenafil-r-1591766288.pdf
https://www.globenewswire.com/fr/news-release/2020/05/04/2026782/0/en/Aspargo-Laboratories-Inc-Announces-Successful-Completion-of-Pre-IND-Meeting-with-FDA-on-Sildenafil-Oral-Spray-for-the-Treatment-of-Erectile-Dysfunction.html
http://www.pharmafile.com/news/546057/pfizer-and-eli-lilly-defeat-lawsuit-over-claims-viagra-and-cialis-cause-cancer
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207178
https://www.pharmacompass.com/pdf/news/med-man-issues-voluntary-nationwide-recall-of-up2-due-to-presence-of-undeclared-sildenafil-1573285451.pdf
https://www.cnbc.com/2019/11/05/reuters-america-update-3-mylan-shares-slide-after-warning-of-hit-to-revenue.html
https://www.forbes.com/sites/victoriaforster/2019/10/10/viagra-may-enhance-common-treatment-for-leukemia/#616cc352da5b
https://ventsmagazine.com/2019/10/04/importance-of-fda-approved-generics-sildenafil/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205791
Market Place
Share 
